Medicamen Biotech standalone net profit declines 36.81% in the March 2017 quarter

Sales rise 23.92% to Rs 22.28 crore

Net profit of Medicamen Biotech declined 36.81% to Rs 1.15 crore in the quarter ended March 2017 as against Rs 1.82 crore during the previous quarter ended March 2016. Sales rose 23.92% to Rs 22.28 crore in the quarter ended March 2017 as against Rs 17.98 crore during the previous quarter ended March 2016.

For the full year,net profit rose 975.00% to Rs 5.16 crore in the year ended March 2017 as against Rs 0.48 crore during the previous year ended March 2016. Sales rose 22.56% to Rs 82.46 crore in the year ended March 2017 as against Rs 67.28 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales22.2817.98 24 82.4667.28 23 OPM %14.6319.13 -13.347.45 - PBDT2.072.64 -22 8.282.61 217 PBT1.572.16 -27 6.360.71 796 NP1.151.82 -37 5.160.48 975

Powered by Capital Market - Live News